Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins, Joseph J. Saseen, Robert L. Page, Brent N. Reed, Kevin Sneed, John B. Kostis, David Lanfear, Salim Virani, Pamela B. Morris

Research output: Contribution to journalArticlepeer-review

218 Citations (Scopus)
Original languageEnglish
Pages (from-to)e468-e495
Issue number21
Publication statusPublished - 22 Nov 2016


  • AHA Scientific Statements
  • anti-arrhythmic agents
  • anticoagulants
  • calcium channel blockers
  • cardiovascular disease
  • drug-related side effects and adverse reactions
  • fenofibrate/fenofibric acid derivatives
  • gemfibrozil
  • hydroxymethylglutaryl-CoA reductase inhibitors
  • immunosuppressive agents

Cite this